Integrated Filing — IndAS
General information about company
| Scrip Code |
539148 |
| NSE Symbol |
SHIVALIK |
| MSEI Symbol |
NA |
| ISIN |
INE788J01021 |
| Name of company |
Shivalik Rasayan Limited |
| Type of company |
Main Board |
| Class of security |
Equity |
| Date of start of financial year |
01-04-2025 |
| Date of end of financial year |
31-03-2026 |
| Date of board meeting when results were approved |
14-11-2025 |
| Date on which prior intimation of the meeting for considering financial results was informed
to the exchange |
05-11-2025 |
| Description of presentation currency |
INR |
| Level of rounding used in financial results |
Lakhs |
| Reporting Type |
Quarterly |
| Reporting Quarter |
Second quarter |
| Nature of report standalone or consolidated |
Consolidated |
| Whether results are audited or unaudited for the quarter ended |
Unaudited |
| Whether results are audited or unaudited for the Year to date for current period ended/year ended |
Unaudited |
| Segment Reporting |
Multi segment |
| Description of single segment |
|
| Start date and time of board meeting |
14-11-2025 16:00:00 |
| End date and time of board meeting |
14-11-2025 17:30:00 |
| Whether cash flow statement is applicable on company |
Yes |
| Type of cash flow statement |
Cash Flow Indirect |
| Declaration of unmodified opinion or statement on impact of audit qualification |
Not applicable |
Financial Results Ind-AS
Amount in (Lakhs)
| Particulars |
3 months/ 6 months ended (dd-mm-yyyy) |
Year to date figures for current period ended (dd-mm-yyyy) |
| A |
Date of start of reporting period |
01-07-2025 |
01-04-2025 |
| B |
Date of end of reporting period |
30-09-2025 |
30-09-2025 |
| C |
Whether results are audited or unaudited |
Unaudited |
Unaudited |
| D |
Nature of report standalone or consolidated |
Consolidated |
Consolidated |
| 1 |
Income |
|
Revenue from operations |
9,384.07 |
18,315.00 |
|
Other income |
38.84 |
98.54 |
|
Total income |
9,422.91 |
18,413.54 |
| 2 |
Expenses |
| (a) |
Cost of materials consumed |
5,329.41 |
9,865.09 |
| (b) |
Purchases of stock-in-trade |
0.00 |
0.00 |
| (c) |
Changes in inventories of finished goods,
work-in-progress and stock-in-trade |
(636.39) |
(389.00) |
| (d) |
Employee benefit expense |
1,566.29 |
2,966.86 |
| (e) |
Finance costs |
221.52 |
483.29 |
| (f) |
Depreciation, depletion and amortisation expense
|
472.96 |
954.50 |
| (f) |
Other Expenses |
| 1 |
Other Expenses |
1,921.48 |
3,570.53 |
|
Total other expenses |
1,921.48 |
3,570.53 |
|
Total expenses |
8,875.27 |
17,451.27 |
| 3 |
Total profit before exceptional items and tax |
547.64 |
962.27 |
| 4 |
Exceptional items |
0.00 |
0.00 |
| 5 |
Total profit before tax |
547.64 |
962.27 |
| 6 |
Tax expense |
|
| 7 |
Current tax |
117.04 |
209.21 |
| 8 |
Deferred tax |
0.11 |
40.44 |
| 9 |
Total tax expenses |
117.15 |
249.65 |
| 10 |
Net movement in regulatory deferral account balances related to profit or loss and
the related deferred tax movement |
0.00 |
0.00 |
| 11 |
Net Profit Loss for the period from
continuing operations |
430.49 |
712.62 |
| 12 |
Profit (loss) from discontinued operations before tax |
0.00 |
0.00 |
| 13 |
Tax expense of discontinued operations |
0.00 |
0.00 |
| 14 |
Net profit (loss) from discontinued
operation after tax |
0.00 |
0.00 |
| 15 |
Share of profit (loss) of associates and joint ventures accounted for using equity
method |
0.00 |
0.00 |
| 16 |
Total profit (loss) for period |
430.49 |
712.62 |
| 17 |
Other comprehensive income net of taxes |
0.00 |
0.00 |
| 18 |
Total Comprehensive Income for the period |
430.49 |
712.62 |
| 19 |
Total profit or loss, attributable to
|
|
|
|
Profit or loss, attributable to owners of parent |
304.59 |
491.43 |
|
Total profit or loss, attributable to non-controlling interests |
125.90 |
221.18 |
| 20 |
Total Comprehensive income for the period attributable to |
|
|
|
Comprehensive income for the period attributable to owners of parent |
|
|
|
Total comprehensive income for the period attributable to owners of parent non-controlling
interests |
|
|
| 21 |
Details of equity share capital |
|
|
Paid-up equity share capital |
787.52 |
787.52 |
|
Face value of equity share capital |
5 |
5 |
| 27 |
Details of debt securities |
|
| 22 |
Reserves excluding revaluation reserve |
|
|
| 23 |
Earnings per share |
|
| i |
Earnings per equity share for continuing operations |
|
|
Basic earnings (loss) per share from continuing operations |
1.93 |
3.12 |
|
Diluted earnings (loss) per share from continuing operations |
1.93 |
3.12 |
| ii |
Earnings per equity share for discontinued operations |
|
|
Basic earnings (loss) per share from discontinued operations |
0 |
0 |
|
Diluted earnings (loss) per share from discontinued operations |
0 |
0 |
| ii |
Earnings per equity share |
|
|
Basic earnings (loss) per share from continuing
and discontinued operations |
1.93 |
3.12 |
|
Diluted earnings (loss) per share from
continuing and discontinued operations |
1.93 |
3.12 |
| 24 |
Debt equity ratio |
|
|
| 25 |
Debt service coverage ratio |
|
|
| 26 |
Interest service coverage ratio |
|
|
| 27 |
Disclosure of notes on financial results |
|
Remarks
Statement of Asset and Liabilities
Amount in (Lakhs)
| Particulars |
Year ended (dd-mm-yyyy) |
| Date of start of reporting period |
01-04-2025 |
| Date of end of reporting period |
30-09-2025 |
| Whether results are audited or unaudited |
Unaudited |
| Nature of report standalone or consolidated |
Consolidated |
|
Assets |
| 1 |
Non-current assets |
|
Property, plant and equipment |
33,638.72 |
|
Capital work-in-progress |
|
|
Investment property |
|
|
Goodwill |
0.00 |
|
Other intangible assets |
65.87 |
|
Intangible assets under development |
|
|
Biological assets other than bearer plants |
|
|
Investments accounted for using equity method |
|
|
Non-current financial assets |
|
|
Non-current investments |
0.00 |
|
Trade receivables, non-current |
|
|
Loans, non-current |
528.00 |
|
Other non-current financial assets |
|
|
Total non-current financial assets |
528.00 |
|
Deferred tax assets (net) |
613.20 |
|
Other non-current assets |
8,423.93 |
|
Total non-current assets |
43,269.72 |
| 2 |
Current assets |
|
|
Inventories |
13,049.13 |
|
Current financial asset |
|
|
Current investments |
0.00 |
|
Trade receivables, current |
11,231.46 |
|
Cash and cash equivalents |
4,683.86 |
|
Bank balance other than cash and cash equivalents |
0.00 |
|
Loans, current |
369.42 |
|
Other current financial assets |
0.00 |
|
Total current financial assets |
16,284.74 |
|
Current tax assets (net) |
0.00 |
|
Other current assets |
7,806.28 |
|
Total current assets |
37,140.15 |
| 3 |
Non-current assets classified as held for sale |
0.00 |
| 4 |
Regulatory deferral account debit balances and related deferred tax Assets |
0.00 |
|
Total assets |
80,409.87 |
|
Equity and liabilities |
|
| 1 |
Equity |
|
|
Equity attributable to owners of parent |
|
|
Equity share capital |
787.52 |
|
Other equity |
57,865.68 |
|
Total equity attributable to owners of parent |
58,653.20 |
|
Non controlling interest |
|
|
Total equity |
58,653.20 |
| 2 |
Liabilities |
|
|
Non-current liabilities |
|
|
Non-current financial liabilities |
|
|
Borrowings, non-current |
2,128.83 |
|
Trade payables, non-current |
|
|
(A) Total outstanding dues of micro enterprises and small enterprises |
0.00 |
|
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises |
0.00 |
|
Total Trade payable |
0.00 |
|
Other non-current financial liabilities |
0.00 |
|
Total non-current financial liabilities |
2,128.83 |
|
Provisions, non-current |
402.12 |
|
Deferred tax liabilities (net) |
0.12 |
|
Deferred government grants, Non-current |
|
|
Other non-current liabilities |
|
|
Total non-current liabilities |
2,531.07 |
|
Current liabilities |
|
|
Current financial liabilities |
|
|
Borrowings, current |
7,909.54 |
|
Trade payables, current |
|
|
(A) Total outstanding dues of micro enterprises and small enterprises |
274.31 |
|
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises |
9,167.21 |
|
Total Trade payable |
9,441.52 |
|
Other current financial liabilities |
|
|
Total current financial liabilities |
17,351.06 |
|
Other current liabilities |
627.39 |
|
Provisions, current |
339.16 |
|
Current tax liabilities (Net) |
907.99 |
|
Deferred government grants, Current |
0.00 |
|
Total current liabilities |
19,225.60 |
| 3 |
Liabilities directly associated with assets in disposal group classified as held for sale |
|
| 4 |
Regulatory deferral account credit balances and related deferred tax liability |
|
|
Total liabilities |
21,756.67 |
|
Total equity and liabilites |
80,409.87 |
|
Disclosure of notes on assets and liabilities |
|
Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results
Amount in (Lakhs)
| Particulars |
3 months/ 6 month ended (dd-mm-yyyy) |
Year to date figures for current period
ended (dd-mm-yyyy) |
| Date of start of reporting period |
01-07-2025 |
01-04-2025 |
| Date of end of reporting
period |
30-09-2025 |
30-09-2025 |
| Whether results are audited
or unaudited |
Unaudited |
Unaudited |
| Nature of report standalone or
consolidated |
Consolidated |
Consolidated |
| 1 |
Segment Revenue (Income) |
|
(net sale/income from each segment should
be disclosed) |
| 1 |
Agrochemicals |
4,437.47 |
8,871.35 |
| 2 |
Active Pharma Ingredient (API) |
0.0014558 |
0.003381 |
| 3 |
Pharma Formulation |
4,716.98 |
9,021.45 |
| 4 |
Unallocated other operating revenue |
0.0008404 |
0.000841 |
|
Total Segment Revenue |
9,384.07 |
18,315.00 |
|
Less: Inter segment revenue |
0.00 |
0.00 |
|
Revenue from operations |
9,384.07 |
18,315.00 |
| 2 |
Segment Result |
|
Profit (+) / Loss (-) before tax and
interest from each segment |
| 1 |
Agrochemicals |
697.25 |
1,341.17 |
| 2 |
Active Pharma Ingredient (API) |
(295.28) |
(591.22) |
| 3 |
Pharma Formulation |
367.18 |
695.62 |
| 4 |
Unallocated other operating revenue |
0.00 |
0.00 |
|
Total Profit before tax |
769.15 |
1,445.57 |
|
i. Finance cost |
221.51 |
483.30 |
|
ii. Other Unallocable Expenditure net off Unallocable income |
0.00 |
0.00 |
|
Profit before tax |
547.64 |
962.27 |
| 3 |
(Segment Asset - Segment Liabilities)
|
|
Segment Asset |
| 1 |
Agrochemicals |
33,227.94 |
33,227.94 |
| 2 |
Active Pharma Ingredient (API) |
10,960.10 |
10,960.10 |
| 3 |
Pharma Formulation |
33,097.08 |
33,097.08 |
| 4 |
Unallocated other operating revenue |
0.00 |
0.00 |
|
Total Segment Asset |
77,285.12 |
77,285.12 |
|
Un-allocable Assets |
0.00 |
0.00 |
|
Net Segment Asset |
77,285.12 |
77,285.12 |
| 4 |
Segment Liabilities |
|
Segment Liabilities |
| 1 |
Agrochemicals |
6,746.77 |
6,746.77 |
| 2 |
Active Pharma Ingredient (API) |
604.20 |
604.20 |
| 3 |
Pharma Formulation |
3,650.74 |
3,650.74 |
| 4 |
Unallocated other operating revenue |
0.00 |
0.00 |
|
Total Segment Liabilities |
11,001.71 |
11,001.71 |
|
Un-allocable Liabilities |
0.00 |
0.00 |
|
Net Segment Liabilities |
11,001.71 |
11,001.71 |
|
Disclosure of notes on segments |
|
Other Comprehensive Income
Amount in (Lakhs)
| Particulars |
3 months/ 6 months ended (dd-mm-yyyy) |
Year to date figures for current period ended (dd-mm-yyyy) |
| A |
Date of start of reporting period |
01-07-2025 |
01-04-2025 |
| B |
Date of end of reporting period |
30-09-2025 |
30-09-2025 |
| C |
Whether results are audited or unaudited |
Unaudited |
Unaudited |
| D |
Nature of report standalone or consolidated |
Consolidated |
Consolidated |
|
Other comprehensive income [Abstract] |
|
| 1 |
Amount of items that will not be reclassified to profit and loss |
|
|
Total Amount of items that will not be reclassified to profit and loss |
|
|
| 2 |
Income tax relating to items that will not be reclassified to profit or loss |
|
|
| 3 |
Amount of items that will be reclassified to profit and loss |
|
|
Total Amount of items that will be reclassified to profit and loss |
|
|
| 4 |
Income tax relating to items that will be reclassified to profit or loss |
|
|
| 5 |
Total Other comprehensive income |
|
|
Cash flow statement, indirect
Amount in (Lakhs)
| Particulars |
Year ended (dd-mm-yyyy) |
| A |
Date of start of reporting period |
01-04-2025 |
| B |
Date of end of reporting period |
30-09-2025 |
| C |
Whether results are audited or unaudited |
Unaudited |
| D |
Nature of report standalone or consolidated |
Consolidated |
|
Statement of cash flows |
|
|
Cash flows from used in operating
activities |
|
|
Profit before tax |
962.27 |
|
Adjustments for reconcile profit (loss) |
|
|
Adjustments for finance costs |
483.29 |
|
Adjustments for decrease (increase) in inventories |
(1,279.10) |
|
Adjustments for decrease (increase) in trade receivables, current |
(1,619.88) |
|
Adjustments for decrease (increase) in trade receivables, non-current
|
0.00 |
|
Adjustments for decrease (increase) in other current assets |
(320.65) |
|
Adjustments for decrease (increase) in other non-current assets |
(1,581.61) |
|
Adjustments for other financial assets, non-current |
0.00 |
|
Adjustments for other financial assets, current |
0.00 |
|
Adjustments for other bank balances |
0.00 |
|
Adjustments for increase (decrease) in trade payables, current |
2,810.54 |
|
Adjustments for increase (decrease) in trade payables, non-current |
0.00 |
|
Adjustments for increase (decrease) in other current liabilities |
(1,595.37) |
|
Adjustments for increase (decrease) in other non-current liabilities
|
66.15 |
|
Adjustments for depreciation and amortisation expense |
954.50 |
|
Adjustments for impairment loss reversal of impairment loss recognised
in profit or loss |
0.00 |
|
Adjustments for provisions, current |
0.00 |
|
Adjustments for provisions, non-current |
0.00 |
|
Adjustments for other financial liabilities, current |
0.00 |
|
Adjustments for other financial liabilities, non-current |
0.00 |
|
Adjustments for unrealised foreign exchange losses gains |
0.00 |
|
Adjustments for dividend income |
0.00 |
|
Adjustments for interest income |
0.00 |
|
Adjustments for share-based payments |
0.00 |
|
Adjustments for fair value losses (gains) |
0.00 |
|
Adjustments for undistributed profits of associates |
0.00 |
|
Other adjustments for which cash effects are investing or financing
cash flow |
0.00 |
|
Other adjustments to reconcile profit (loss) |
0.00 |
|
Other adjustments for non-cash items |
0.00 |
|
Share of profit and loss from partnership firm or association of
persons or limited liability partnerships |
0.00 |
|
Total adjustments for reconcile
profit (loss) |
(2,082.13) |
|
Net cash flows from (used in)
operations |
(1,119.86) |
|
Dividends received |
0.00 |
|
Interest paid |
0.00 |
|
Interest received |
(79.46) |
|
Income taxes paid (refund) |
485.00 |
|
Other inflows (outflows) of cash |
0.00 |
|
Net cash flows from (used in)
operating activities |
(1,684.32) |
|
Cash flows from used in
investing activities |
|
|
Cash flows from losing control of subsidiaries or other businesses |
0.00 |
|
Cash flows used in obtaining control of subsidiaries or other businesses |
0.00 |
|
Other cash receipts from sales of equity or debt instruments of other
entities |
0.00 |
|
Other cash payments to acquire equity or debt instruments of other entities
|
0.00 |
|
Other cash receipts from sales of interests in joint ventures |
0.00 |
|
Other cash payments to acquire interests in joint ventures |
0.00 |
|
Cash receipts from share of profits of partnership firm or association of
persons or limited liability partnerships |
0.00 |
|
Cash payment for investment in partnership firm or association of persons or
limited liability partnerships |
0.00 |
|
Proceeds from sales of property, plant and equipment |
0.00 |
|
Purchase of property, plant and equipment |
1,655.84 |
|
Proceeds from sales of investment property |
0.00 |
|
Purchase of investment property |
0.00 |
|
Proceeds from sales of intangible assets |
0.00 |
|
Purchase of intangible assets |
0.00 |
|
Proceeds from sales of intangible assets under development |
0.00 |
|
Purchase of intangible assets under development |
0.00 |
|
Proceeds from sales of goodwill |
0.00 |
|
Purchase of goodwill |
0.00 |
|
Proceeds from biological assets other than bearer plants |
0.00 |
|
Purchase of biological assets other than bearer plants |
0.00 |
|
Proceeds from government grants |
0.00 |
|
Proceeds from sales of other long-term assets |
0.00 |
|
Purchase of other long-term assets |
0.00 |
|
Cash advances and loans made to other parties |
0.00 |
|
Cash receipts from repayment of advances and loans made to other parties |
0.00 |
|
Cash payments for future contracts, forward contracts, option contracts and
swap contracts |
0.00 |
|
Cash receipts from future contracts, forward contracts, option contracts and
swap contracts |
0.00 |
|
Dividends received |
0.00 |
|
Interest received |
79.47 |
|
Income taxes paid (refund) |
0.00 |
|
Other inflows (outflows) of cash |
0.00 |
|
Net cash flows from (used in)
investing activities |
(1,576.37) |
|
Cash flows from used in
financing activities |
|
|
Proceeds from changes in ownership interests in subsidiaries |
0.00 |
|
Payments from changes in ownership interests in subsidiaries |
0.00 |
|
Proceeds from issuing shares |
84.82 |
|
Proceeds from issuing other equity instruments |
5,271.97 |
|
Payments to acquire or redeem entity's shares |
0.00 |
|
Payments of other equity instruments |
0.00 |
|
Proceeds from exercise of stock options |
0.00 |
|
Proceeds from issuing debentures notes bonds etc |
0.00 |
|
Proceeds from borrowings |
653.30 |
|
Repayments of borrowings |
0.00 |
|
Payments of lease liabilities |
0.00 |
|
Dividends paid |
78.75 |
|
Interest paid |
0.00 |
|
Income taxes paid (refund) |
0.00 |
|
Other inflows (outflows) of cash |
(783.73) |
|
Net cash flows from (used in)
financing activities |
5,147.61 |
|
Net increase (decrease) in cash
and cash equivalents before effect of exchange rate changes |
1,886.92 |
|
Effect of exchange rate changes
on cash and cash equivalents |
|
|
Effect of exchange rate changes on cash and cash equivalents |
0.00 |
|
Net increase (decrease) in cash
and cash equivalents |
1,886.92 |
|
Cash and cash equivalents cash flow statement at beginning of period
|
2,796.95 |
|
Cash and cash equivalents cash
flow statement at end of period |
4,683.87 |